EUnetHTA releases the second version of its methodological guideline “Process of information retrieval for systematic reviews and health technology assessments on clinical effectiveness”
The aim of this methodological guideline is to provide an up-to-date and transparent overview of the whole information retrieval process for Systematic reviews and HTAs on clinical effectiveness. In particular, the requirements presented in this methodological guideline aim to provide orientation
We would like to confirm some dates for key EUnetHTA events throughout the remainder of JA3. Please ensure to put these in your agenda: 25-26 March, 2020 - Heads of Agencies Meeting (Spring 2020) 1-2 April, 2020 - EUnetHTA Assembly & Forum 2020 29-30 October, 2020 - Heads
PTJA09 – ‘Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD)’ project plan now available
The final project plan of the relative effectiveness of ‘Brolucizumab for the treatment of adults with neovascular (wet) age-related macular degeneration (AMD)' is now available for access. The final assessment report will be published on 12th March, 2020. Below is the documentation
The final assessment report and related documents for the Other Technologies Collaborative Assessment 'Point-of-care Tests (POCT): D-Dimer and Troponin' are now available for access. Troponin and D-dimer point of care tests can be used to aid the diagnosis of patients with
EUnetHTA is pleased to announce the new Implementation Report with Appendices are now available for access. The report covers the updated use and uptake on all Joint Action 3 assessments. The report and all related documentation is available at this link, or
PTJA06 – “Polatuzumab vedotin in combination with bendamustine and rituximab for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL)” final project plan now available.
The final project plan of the assessment on polatuzumab is now available. The final assessment report will be published on 13th February, 2020. Please access the final project plan at the following link: PTJA06 Final Project Plan
The final assessment report and related documents for the Other Technologies Collaborative Assessment 'Lithium triborate (LBO) laser for photoselective vaporisation of the prostate (PVP) in the treatment of benign prostatic hyperplasia (BPH)' are now available for access. The present assessment addressed
EUnetHTA is pleased to announce that the updated final project plan now with adapted timelines, and related documents from external experts for the Other Technologies Collaborative Assessment OTCA23 "Biodegradable rectum spacers to reduce toxicity for prostate cancer'' are now available
PTJA08 – “Siponimod for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features of inflammatory activity” project plan now available.
The Final Project Plan of the assessment on siponimod is now available. The final assessment report will be published on 13th February, 2020. Please access the Final Project Plan at the following link: PTJA08 Final Project Plan
We are pleased to announce that the final assessment report for OTCA20 ‘Prophylactic or therapeutic use of endoanchoring systems in endovascular aortic aneurysm repair (EVAR/TEVAR)’, together with the fact check comments from manufacturers and comments from external experts including the